Evolent Health, Inc. (EVH) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 492.83M USD | Liabilities, Current |
| Cash and equivalents | 115.70M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 449.12M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $492.83M | $115.70M | (m) | $449.12M | (m) | (m) |
| 2026-03-31 | (m) | $381.24M | $142.03M | (m) | $314.16M | (m) | (m) |
| 2025-12-31 | (m) | $385.26M | $151.86M | (m) | $309.86M | (m) | (m) |
| 2025-09-30 | (m) | $429.93M | $116.65M | (m) | $386.56M | (m) | (m) |
| 2025-06-30 | (m) | $557.52M | $151.00M | (m) | $358.76M | (m) | (m) |
| 2025-03-31 | (m) | $739.10M | $246.55M | (m) | $430.50M | (m) | (m) |
| 2024-12-31 | (m) | $715.50M | $104.20M | (m) | $414.68M | (m) | (m) |
| 2024-09-30 | (m) | $523.68M | $96.58M | (m) | $407.90M | (m) | (m) |
| 2024-06-30 | (m) | $483.37M | $101.25M | (m) | $373.73M | (m) | (m) |
| 2024-03-31 | (m) | $659.02M | $165.15M | (m) | $427.74M | (m) | (m) |
| 2023-12-31 | (m) | $674.24M | $192.82M | (m) | $446.75M | (m) | (m) |
| 2023-09-30 | (m) | $615.29M | $184.54M | (m) | $394.23M | (m) | (m) |
| 2023-06-30 | (m) | $540.90M | $142.53M | (m) | $345.28M | (m) | (m) |
| 2023-03-31 | (m) | $457.65M | $157.52M | (m) | $262.76M | (m) | (m) |
| 2022-12-31 | (m) | $433.44M | $188.20M | (m) | $254.68M | (m) | (m) |
| 2022-09-30 | (m) | $382.02M | $156.76M | (m) | $187.63M | (m) | (m) |
| 2022-06-30 | (m) | $342.84M | $193.07M | (m) | $118.53M | (m) | (m) |
| 2022-03-31 | (m) | $382.46M | $210.16M | (m) | $179.27M | (m) | (m) |
| 2021-12-31 | (m) | $445.49M | $266.28M | (m) | $130.60M | (m) | (m) |
| 2021-09-30 | (m) | $367.20M | $252.50M | (m) | $175.23M | (m) | (m) |
| 2021-06-30 | (m) | $403.27M | $207.27M | (m) | $242.50M | (m) | (m) |
| 2021-03-31 | (m) | $414.51M | $236.03M | (m) | $185.10M | (m) | (m) |
| 2020-12-31 | (m) | $401.78M | $340.49M | (m) | $125.99M | (m) | (m) |
| 2020-09-30 | (m) | $365.50M | $370.51M | (m) | $95.32M | (m) | (m) |
| 2020-06-30 | (m) | $245.12M | $98.27M | (m) | $95.84M | (m) | (m) |
| 2020-03-31 | (m) | $236.25M | $67.94M | (m) | $107.51M | (m) | (m) |
| 2019-12-31 | (m) | $192.77M | $101.01M | (m) | $75.67M | (m) | (m) |
| 2019-09-30 | (m) | $259.85M | $96.73M | (m) | $74.87M | (m) | (m) |
| 2019-06-30 | (m) | $172.87M | $92.82M | (m) | $71.38M | (m) | (m) |
| 2019-03-31 | (m) | $163.68M | $170.82M | (m) | $65.63M | (m) | (m) |
| 2018-12-31 | (m) | $269.36M | $228.32M | (m) | $80.21M | (m) | (m) |
| 2018-09-30 | (m) | $139.41M | $221.84M | (m) | $60.05M | (m) | (m) |
| 2018-06-30 | (m) | $136.19M | $197.98M | (m) | $70.85M | (m) | (m) |
| 2018-03-31 | (m) | $116.94M | $200.32M | (m) | $66.14M | (m) | (m) |
| 2017-12-31 | (m) | $132.70M | $238.43M | (m) | $48.95M | (m) | (m) |
| 2017-09-30 | (m) | $105.47M | $287.14M | (m) | $43.97M | (m) | (m) |
| 2017-06-30 | (m) | $101.76M | $99.97M | (m) | $45.80M | (m) | (m) |
| 2017-03-31 | (m) | $104.44M | $104.30M | (m) | $44.64M | (m) | (m) |
| 2016-12-31 | (m) | $131.94M | $134.56M | (m) | $40.63M | (m) | (m) |
| 2016-09-30 | (m) | $65.33M | $109.78M | (m) | $21.99M | (m) | (m) |
| 2016-06-30 | (m) | $56.73M | $105.14M | (m) | $30.34M | (m) | (m) |
| 2016-03-31 | (m) | $52.55M | $111.29M | (m) | $25.22M | (m) | (m) |
| 2015-12-31 | (m) | $59.51M | $145.73M | (m) | $20.38M | (m) | (m) |
| 2015-09-30 | (m) | $89.84M | $208.16M | (m) | $30.54M | (m) | (m) |
| 2015-06-30 | (m) | $60.81M | $219.37M | (m) | $24.04M | (m) | (m) |
| 2015-03-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $0.00 | $0.00 | (m) | $0.00 | (m) | (m) |
| 2014-09-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | $5.25M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |